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ABSTRACT 
 
Contaminants such as pharmaceuticals are of increasing concern due to their 
ubiquitous use and persistence in surface waters worldwide. Limited attention has been 
paid to the effects of pharmaceuticals on marine life, despite widespread detection of 
these contaminants in the marine environment. Of the existing studies, the majority assess 
the negative effects of pharmaceuticals over an exposure period of 30 days or less and 
focus on cellular and subcellular biomarkers. Longer studies are required to determine if 
chronic contaminant exposure poses risks to marine life at environmentally relevant 
concentrations. Also scarce in the literature is examination of whole organism effects to 
identify potential community-level consequences. Two long-term studies with the 
antidepressant pharmaceutical, fluoxetine (the active constituent in Prozac®) were 
conducted to determine whether nominal concentrations detected in estuarine and coastal 
environments affect organism health and interactions.  
First, we measured whole organism metrics in the California mussel, Mytilus 
californianus over a period of 107 days. Specifically, we measured algal clearance rates, 
growth, and condition indices for both reproductive and overall health. We found that 
fluoxetine negatively affects all measured characteristics, however many effects are 
mediated by length of exposure. Perhaps the most notable result was that mussels spiked 
with fluoxetine cleared less algae after 30 days of exposure. Reduced growth and 
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condition indices likely are a consequence of improper nutrition among fluoxetine-treated 
mussels. Any level of fluoxetine significantly affected the gonadosomatic index after 47 
days. The results from this study on mussels fill an important data gap, highlighting 
organism-level effects of chronic exposure periods; such data more explicitly identify the 
impacts of pharmaceuticals and other contaminants on marine communities and 
ecosystems. 
Fluoxetine has also been documented to affect the behavior of fish and 
invertebrates, including freshwater and marine bivalves, crustaceans, and fish. Given that 
other crustaceans exhibited increased activity levels under fluoxetine exposure, we 
hypothesized that this would subject them to greater predation risk. In our second 
exposure study, we assessed whether a similar range of fluoxetine concentrations used in 
the mussel study altered the risk behavior of the Oregon mud crab, Hemigrapsus 
oregonensis, in response to a common predator, the red rock crab, Cancer productus. We 
conducted this study for 60 days, conducting day and night behavioral trials (with and 
without predators) four times a week. We found that crabs exposed to any amount of 
fluoxetine (3 or 30 ng/L) had increased activity levels relative to controls; however 
behaviors of 3 ng/L-spiked crabs were not always significantly different from controls. 
Among control crabs, day and night trials yielded similar results, where a clear response 
to the addition of the predator was observed. Crabs dosed with fluoxetine exhibited more 
foraging and active behaviors in the presence of the predator. Additionally, crabs spiked 
with fluoxetine at 30 ng/L had the greatest risk of mortality either by predation by red 
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rock crabs or due to more aggressive behaviors among conspecifics. The results of this 
study shed light on a particularly unexplored area of contaminants research: how do 
psychoactive pharmaceuticals affect animal behavior when exposed to the low 
concentrations persisting in the aquatic environment for a prolonged period of time? 
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Chapter 1: Introduction 
 
Whole suites of pharmaceuticals and their derivatives routinely enter the aquatic 
realm through human wastewater effluent, septic systems, and animal waste runoff from 
agricultural lands (Kolpin et al. 2002; Kinney et al. 2006; Ramirez et al. 2009). While 
these drugs are often detected at very low concentrations (e.g., ng/L; Fent et al. 2006),  
these compounds are designed to illicit cellular responses (e.g., enzymes, receptors) and 
should not be regarded as trivial threats to aquatic organisms (Meredith-Williams et al. 
2012; Franzellitti et al. 2014).  Additionally, many pharmaceuticals are persistent in 
aquatic environments, putting aquatic organisms at risk of chronic exposure and 
bioaccumulation (Ramirez et al. 2009; Meredith-Williams et al. 2012). Numerous studies 
have documented acute and chronic toxicities of countless pharmaceuticals on aquatic 
organisms (Trudeau et al. 2005; Corcoran et al. 2010; Brausch et al. 2012); however 
studies on coastal and marine organisms are lacking (Brooks et al. 2009; Brodin et al. 
2014; Gaw et al. 2014). With large and growing human populations along coastlines, 
much remains to be learned about the effects of pharmaceuticals on marine organisms to 
better inform best management practices (Seiler et al. 2002; Valbonesi et al. 2003; Regoli 
and Giuliani 2013).  
Despite shared interests in pharmaceuticals as stressors to organisms and use of 
the same species and similar endpoints, limited cross-citation suggests that the disciplines 
of ecology and ecotoxicology are growing independently (Brodin et al. 2014).  Most 
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ecotoxicological data are based on acute exposure periods of less than 24 hours with 
recent studies running up to 30 days (Daugton and Ternes 1999; Brooks et al 2009; Gaw 
et al. 2014). While useful for assessing how pharmaceuticals may alter cellular activities, 
this approach is insufficient in length and scope to determine organism- or ecosystem-
level chronic effects. Ecologists are interested in how the presence of pharmaceuticals 
may alter organism behavior (Hazleton et al. 2013; Chen et al. 2015), physiological 
functioning (Fong 1998; Di et al. 2014), and ultimately how this may shift community 
and ecosystem dynamics (Brodin et al. 2014; Hazleton et al. 2014). Short term (30 days 
or less) chronic exposure studies allow for only limited inferences by ecologists about the 
effects of pharmaceuticals on ecosystem processes. Long-term exposure studies with 
concentrations that reflect those detected in the environment are required to answer most 
ecological questions (Gaw et al. 2014, Brodin et al. 2014).  
Estuarine and rocky intertidal organisms are particularly at risk from 
pharmaceuticals as environmental stressors (Fong & Ford 2014), however data from 
prolonged studies are lacking (Berninger & Brooks 2010; Gaw et al. 2014).  Exposure to 
heavy metals, pesticides, petroleum and other legacy contaminants have also been shown 
to affect marine organisms by altering habitat preference, shifting migration patterns, or 
increasing negative species interactions (Fleeger et al. 2003; Khoury et al. 2009; Eades & 
Waring 2010; Fukunaga et al. 2010). Such alterations to normal behaviors have been 
linked to reduced fitness, and changes to population structure and ecosystem function 
(Frid & Dill 2002; Fahrig 2007; Ings et al. 2009). Experiments with pharmaceuticals can 
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be designed in a similar fashion by substituting the nominal concentrations of the drug or 
its constituents as the stressor(s), and determining organism- or community-level 
responses.  
Selective serotonin reuptake inhibitor (SSRI) anti-depressants such as fluoxetine 
hydrochloride (Prozac®) are among the more prevalent categories of pharmaceuticals 
detected in the marine environment (Kreke and Dietrich 2008; Vasskog et al. 2008; 
Brodin et al. 2014; Gaw et al. 2014). SSRIs have been developed to delay the reuptake of 
serotonin, moderating neurotransmission in the human brain. However, serotonin, 
serotonin analogs, and serotonin-altering drugs have been shown to dramatically affect 
several marine species (see Fong & Ford 2014 for a recent review). Serotonin is an 
important neuromodulater in bivalves, regulating gill cilliary activity, oocyte maturation, 
and the induction of spawning (Gibbons and Castanga 1984). In crustaceans, serotonin is 
well known to affect behaviors though stimulating the release of hyperglycaemic, 
neurodepressing, moult-inhibiting, and gonad-stimulating hormones (Fong and Ford 
2014).)  Several other studies have demonstrated that fluoxetine leads to adverse 
physiological and behavioral outcomes in aquatic organisms that could alter their 
functional roles within the community (Perreault et al. 2003; Lynn et al. 2007; Stanley et 
al. 2007; Mennigen et al. 2010; Schultz et al. 2011; Dzieweczynski & Herbert 2012; 
Kohlert et al. 2012; Bossus et al. 2013; Barry 2013; Munari et al. 2014; Chen et al. 2015).   
The objectives of the fluoxetine case study were to 1) assess whole-organism 
metrics on the California mussel, Mytilus californianus during a long-term exposure 
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experiment with environmentally relevant concentrations of fluoxetine detected in 
nearshore marine environments (Chapter 2); and 2) determine if prolonged exposure to 
similar fluoxetine concentrations affected activity levels, predation risk behavior, and 
mortality in the Oregon shore crab, Hemigrapsus oregonensis with exposure to red rock 
crabs, Cancer productus (Chapter 2). These two studies are critical steps towards 
addressing how fluoxetine and other pharmaceutical contaminants may affect marine and 
estuarine species in two very different ways. This work will help fill existing data gaps to 
better inform best management practices and cradle-to-grave stewardship of 
pharmaceutical drugs so they can be reduced or eliminated before entering the marine 
environment.  
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Chapter 2: Long-term exposure to fluoxetine reduces growth and reproductive potential 
in the mussel, Mytilus californianus 
Introduction 
  Pharmaceuticals are commonly detected in the aquatic environment (Daughton 
and Ternes 1999; Ankley et al. 2007; Brausch and Rand 2011; Boxall et al. 2012). Due to 
dilution, absorption, and physical breakdown, most pharmaceuticals are detected at very 
low concentrations (e.g., ng/L; Fent et al. 2006). However as drugs, these compounds are 
designed to illicit cellular responses (e.g., enzymes, receptors) and therefore their 
nominal concentrations should not be regarded as trivial threats to aquatic organisms 
(Meredith-Williams et al. 2012; Franzellitti et al. 2014).  Because of their ubiquitous use, 
many pharmaceuticals are persistent in aquatic environments, putting aquatic organisms 
at risk of chronic exposure and bioaccumulation (Ramirez et al. 2009; Meredith-Williams 
et al. 2012). Numerous studies have documented acute and chronic toxicities of countless 
pharmaceuticals on aquatic organisms (Trudeau et al. 2005; Corcoran et al. 2010; 
Brausch et al. 2012); however studies on coastal and marine organisms are fewer (Brooks 
et al. 2009). With large human populations along coastlines much remains to be learned 
about the effects of pharmaceuticals on marine organisms to better inform best 
management practices (Seiler et al. 2002; Valbonesi et al. 2003; Regoli and Giuliani 
2013). 
There is debate over whether standard ecotoxicological methods are sufficient for 
determining chronic exposure effects on organisms at environmentally relevant 
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concentrations (Corcoran et al. 2010; Franzellitti et al. 2014). Most ecotoxicological data 
are based on acute exposure periods of less than 24 hours with recent studies running up 
to 30 days (Daugton and Ternes 1999; Brooks et al 2009; Gaw et al. 2014). While useful 
for assessing how pharmaceuticals may alter cellular activities, this approach is 
insufficient in length and scope to determine organism- or ecosystem-level chronic 
effects. Ecologists are interested in how the presence of pharmaceuticals may alter 
organism behavior (Hazleton et al. 2013; Chen et al. 2015), physiological functioning 
(Fong 1998; Di et al. 2014), and ultimately how this may shift community and ecosystem 
dynamics (Hazleton et al. 2014). Depending on the life history of the organism (e.g., long 
vs. short life span), short term (30 days or less) chronic exposure studies allow for only 
limited inferences by ecologists about the effects of pharmaceuticals on ecosystem 
processes. Long-term exposure studies with concentrations that reflect those detected in 
the environment are required to answer most ecological questions for long-lived species.  
Among the more prevalent categories of pharmaceuticals detected in the marine 
environment are selective serotonin reuptake inhibitor (SSRI) anti-depressants such as 
fluoxetine hydrochloride (Prozac®) (Kreke and Dietrich 2008; Vasskog et al. 2008). 
These drugs have been developed to delay the reuptake of serotonin, moderating 
neurotransmission in the human brain. However, serotonin is also an important 
neuromodulater in bivalves, regulating gill cilliary activity, oocyte maturation, and the 
induction of spawning (Gibbons and Castanga 1984; Fong and Ford 2014).  Increased 
serotonin levels in mussels via fluoxetine exposure have been shown to alter several 
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important cellular activities that lead to reduced health status (Franzellitti et al. 2014; 
Munari et al. 2014). Fong and Molnar (2008) found that norfluoxetine, the active 
metabolite of fluoxetine, induced spawning and parturition in both estuarine and 
freshwater bivalves at high concentrations (e.g. 29.5 mg/L). Several other studies have 
demonstrated that fluoxetine leads to adverse physiological and behavioral outcomes in 
marine invertebrates that could alter their functional roles within the community (Stanley 
et al. 2007; Oakes et al. 2010; Bossus et al. 2013; Munari et al. 2014; Chen et al. 2015). 
Bivalves such as mussels and oysters are at risk of chronic exposure to fluoxetine 
particularly downstream from effluent-dominated coastal waterways (Brooks et al. 2005; 
Brooks et al. 2006; Kwon and Armburst 2006; Kreke and Dietrich 2008). Oxidative 
stress was observed in the marine mussel Mytilus galloprovincialis after 15 days of 
exposure to fluoxetine at a concentration of only 75ng/L, a concentration detected in 
surface waters (Gros et al. 2006; Metcalfe et al. 2003; Gonzalez-Rey and Bebianno 
2013). Franzellitti et al. (2014) found that fluoxetine had adverse outcomes on cell 
signaling and reduced the health status of the marine mussel M. galloprovincialis 
following 7-day exposure to a range of concentrations detected in the marine 
environment (e.g., 0.03-300 ng/L). But how do marine mussels react to this range of 
fluoxetine concentrations over a longer exposure period (i.e., over 30 days) and in terms 
of whole body metrics?  
I designed a laboratory experiment to build on the findings of other marine 
mussel- fluoxetine exposure studies where adverse effects among cellular biomarkers 
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were identified at high concentrations for short time periods. I hypothesized that whole- 
mussel metrics would be affected by four low, but environmentally-relevant, fluoxetine 
concentrations over longer exposure periods. Specifically, I tested whether growth, body 
and reproductive condition indices, and the rates of algae cleared by Mytilus 
californianus mussels were affected by fluoxetine exposure over time. We measured 
these variables at 47, 67, and 107 days of exposure. This study addresses two critical gaps 
in emerging pharmaceutical contaminants research: 1) the impacts to whole organism 
physiology and function; and 2) the effects of prolonged exposure periods. 
 
Materials and methods  
 Experimental organisms and holding conditions  
M. californianus mussels were collected from a single location on the jetty north 
of Rockaway Beach, Oregon (45°39’18.4”N, 123°56’31.2”W) on August 1, 2014 and 
transported in chilled seawater to the laboratory at Portland State University.  Upon 
arrival, mussels were measured and sorted into size classes. From these, 21 mussels were 
randomly distributed into 25 housing tanks (~ 64 L each) with a mean total biomass of 
87.13 ± 1.17 g per tank. Mean length and mass of individual mussels did not differ 
among treatments (mean length = 32.22 ± SE (0.35) mm; one-way ANOVA, P = 0.1; 
mean mass = 4.19 ± 0.13 g; P = 0.2) or tanks (one-way ANOVA, P > 0.7 in both cases; 
See Appendix A for full summary of mussel metrics by treatment group).  
Mussels were allowed to acclimate to laboratory conditions for one month before 
the exposure study began.  Each housing tank had an independent water chilling and 
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filtration system (Aquatic Enterprises). Seawater was prepared using Instant Ocean and 
deionized water with salinity and temperature maintained at 35 PSU and 15 °C 
respectively, to replicate conditions at the collection site.  We monitored water chemistry 
(i.e. ammonia, pH, nitrate, and nitrite) every two weeks to ensure levels were appropriate 
for mussels. To reduce buildup of animal waste products, 20% of the seawater was 
replaced with fresh seawater every 20 days. Tanks were dosed with fluoxetine following 
water changes. Light cycle conditions were maintained at 10 h of dark and 14 h of 
daylight. During the acclimation period, mussel health and condition were monitored. A 
total of 4 mussels died during acclimation and were immediately replaced with one of the 
extra mussels from the original collection. During the exposure study, there was no 
mussel mortality.  
Twice weekly, mussels were batch fed Shellfish Diet 1800® (Reed Mariculture) 
diluted tenfold with seawater. The algae in the Shellfish Diet 1800® is a combination of 
six marine microalgae Isochrysis, Pavlova, Tetraselmis, Chaetocerous calcitrans, 
Thalassiosira weissflogii and Thalassiosira pseudonana with cell diameter sizes ranging 
from 5 to 16 µm. Mussels were fed algae according to the total biomass in each tank. As 
mussels were removed from the tanks for subsampling, algae diet was adjusted to the 
total biomass in each tank (see Appendix A for total biomass of mussels per treatment 
over the course of the study). 
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Experimental design  
We assigned 21 mussels to each tank representing one of five treatments of 
fluoxetine ranging from 0 to 300 ng/L, which covers the range detected in the marine 
environment (Franzellitti et al. 2014). Treatment groups were 0.3, 3, 30, and 300 ng/L of 
fluoxetine and a control with no fluoxetine (Figure 2.1). Our experimental units were the 
individual tanks (n=25) with 5 replicate tanks nested within each treatment group.  Each 
tank was subsampled on days 47, 67, and 107 with 6, 6, and 9 mussels sacrificed 
respectively. With three sample periods the total number of observations was 75.  A set 
of 5 tanks with no mussels was used to determine a baseline for algae removed by the 
tank filtration system during algal clearance trials. We note that one of the no-mussel 
tanks malfunctioned after 20 days into the experiment and was excluded from further 
analyses, reducing no-mussel tank replicates to 4. 
Before each dosing period, fluoxetine solutions were prepared using a stock 
solution of 1.0 mg/mL fluoxetine hydrochloride (Sigma-Aldrich) dissolved in nanopure 
water.  Each treatment concentration (0.3, 3.0, 30.0, and 300.0ng/L) was prepared using 
separate dosing solutions, which were prepared through serial dilution of the original 
stock solution.  Every 10 days, the tanks were dosed by adding 193µL of the appropriate 
fluoxetine dosing solution into each tank. Controls without fluoxetine received 193µL of 
nanopure water on dosing days.   
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Figure 2.1 Schematic of aquarium set up, with the order of treatment tanks randomized. 
Treatment groups included: Control, 0.3 ng L -1, 3.0 ng L -1, 3.0 ng L -1, 30 ng L -1, 300 
ng L -1, No Mussel (NM) 3.0 ng L -1. 
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Fluoxetine exposure study  
1. Algal clearance  
 On feeding days, a 10 mL seawater sample was obtained within 5 minute after the 
algae mixture was added to each of the tanks to allow for thorough mixing.  Mussels 
were allowed to feed for 3 hours before an additional 10mL sample was extracted. These 
samples served as initial and final concentrations, respectively.  From each sample, we 
counted algal cells in three 0.5 mL aliquots using a Beckman Coulter Counter (model Z1, 
100 µm aperture) and determined the mean initial and final concentrations within each 
tank.  We collected a total of 11 samples over the course of the 107-day study.  
Filtering rates were estimated from the rate of change in suspended particle 
concentrations. Following Coughlan (1969), we based filtering rates on four assumptions: 
a) the reduction in the concentration of particles is due to filtration by the animal, and to 
settling, b) mussel pumping rate is constant, c) particle retention is 100% efficient and d) 
there is homogenous suspension of particles. A set of identical tanks without mussels 
(n=4) served as blanks for feeding trials.  For each of the 11 sample dates, clearance rates 
for each mussel were calculated using the following formula (Coughlin 1969): 
CR= (M/n) [ln (C0/Ct)/t] – [ln (C0blank/Ctblank)/t] 
where CR = clearance rate (cells-1mL-1min-1); M = volume of seawater in each tank (mL); 
n = number of mussels in tank; t = feeding time (min); C0 = initial concentration of 
particles in tank; Ct  = final concentration of particles in tank. C0blank = initial 
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concentration of particles in tank without mussels; Ctblank = final concentration of 
particles in tank without mussels 
2. Mussel growth  
Shell length was measured from the umbo to the ventral margin using digital 
calipers (Mitutoyo 500 196-30) with an accuracy of ±0.01mm. Biomass measurements 
were made by weighing towel-dried mussels on an analytical balance (Southern 
Laboratories) with an accuracy of ±0.001g. Two mussel growth estimates (increase in 
shell length and biomass) were determined as the change between final and initial 
measurements.  
3. Body condition 
 Three mussels from each subsample period (n=225) were dissected to assess 
condition and gonadosomatic indices. We separated the somatic and gonadal tissues, 
desiccated each in a drying oven set at 60°C for 48 hours (Quincy Labs), and recorded 
their respective dry weights (dw). We calculated the gonadosomatic index (GSI) for each 
mussel using the following equation:  
GSI= [gonads dw (mg)/total soft tissue dw (mg)] x 100 
Additionally, the condition index (CI) was calculated for each mussel using the equation:  
CI= [total tissue dw (mg)/shell length (mm)] x 100   
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4. Statistical analysis  
For each sampling period, we averaged within-tank means for mussel growth, 
GSI, CI, and algal clearance parameters. Normality and homogeneity of variances were 
assessed through graphical inspection of the model residuals and respective Shapiro-
Wilk’s and Levene’s tests, which indicated a need for data transformation. Algal 
clearance data underwent a Box-Cox transformation (Box and Cox 1964) and mussel 
growth and body condition data were log-transformed. The assumption of sphericity was 
determined for each parameter using the Mauchly test and adjusted using the 
Greenhouse-Geisser correction. In order to determine the effects of fluoxetine treatments 
on measured response variables we ran repeated-measures ANOVAs with fluoxetine 
treatment and sample date as factors with tanks included as an error term to account for 
the non-independence between samples. Main effects were considered significant at 
α=0.05. Mixed-effects models were generated using the lme4 package in R (Bates et al. 
2015). Fluoxetine treatment and sample date were treated as fixed factors while the tanks 
were treated as a random factor. Using the multcomp package in R, I generated post-hoc 
multiple pairwise comparisons (with a Bonferroni correction) between treatment groups 
and sample dates for each measured parameter (See Appendices B-E for pairwise 
comparisons of treatment by sample date). All statistical analyses were performed using 
R statistical platform (RStudio Version 3.2.2 (2015)).  
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Results 
1. Algal Clearance   
Mean clearance rates differed among treatment groups (ANOVA: F4, 20 = 34.4, P < 
0.001, Figure 2.2), being higher in the controls [mean = 63.0 (SE 3.7) cells mL-1min-1] 
than in the treatment groups [36.3 (SE 4.2) cells mL-1min-1; Table 1, Figure 2.2]. Mean 
clearance rates also differed between sample dates (F10, 20 = 46.0, P < 0.001; Table 2) 
being higher towards the end of the study [76.7 (SE 4.7) cells mL-1min-1] than at 30 
days since the start [38.2 (SE 3.1) cells mL-1min-1], suggesting that clearance rates were 
variable with time. There was an interaction between treatment and sample date (F40, 20 
= 3.0, P < 0.001), indicating that the effect of treatment was mediated by sample date.  
In general, clearance rates were inversely proportional to fluoxetine concentrations, 
where mussels treated with 30 and 300 ng/L cleared algae at a slower rate than the 
lower treatment groups (0.3 and 3 ng/L) and controls (see Table 2.1 for full list of 
summary statistics). 
Table 2.1. Summary statistics from algal clearance trials: mean, minimum, and 
maximum values ± SE. Clearance rates were calculated as cleared algal cells mL-1min-1.  
 
Treatment Mean  Min Max 
Control 63.0 ± 3.7 38.8 ± 1.8 119.2 ± 4.3 
0.3 ng/L 45.2 ± 3.7 19.8 ± 2.6 93.3 ± 2.7 
3 ng/L 41.8 ± 4.2 18.7 ± 3.8 75.1 ± 4.9 
30 ng/L 31.9 ± 4.2 18.6 ± 3.4 57.9 ± 8.3 
300 ng/L 26.3 ± 4.6 13.2 ± 1.2 47.0 ± 7.8 
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2. Mussel growth 
Growth in shell length varied by treatment level (ANOVA: F4, 20 = 22.6, P < 0.001, 
Table 2, Figure 2.3 A), with faster growth in controls [0.22 (SE 0.04) mm] than in 
treatment [0.12 (SE 0.02) mm; Figure 2.3 A] groups. While there was also an effect of 
the sample date (F2, 20 = 18.7, P < 0.001) there was no interaction between treatment 
and sample date (F8, 20 = 0.7, P = 0.3) indicating that treatment effects are not 
dependent on sample date. Overall growth in shell length followed a similar pattern 
over time: lower treatment groups (0.3 and 3 ng/L) grew at a similar rate to controls and 
were much greater than the 30 and 300 ng/L treatment groups. Post-hoc Tukey tests 
indicated that controls were significantly different from 3.0 ng/L (P = 0.04) but not 0.3 
ng/L (P = 0.08) treatment groups, while 30 and 300 ng/L were not different from each 
other (P = 0.81).  
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Figure 2.2. Clearance rates of mussels; samples collected during 11 feedings over study 
duration. Clearance rates were defined as the amount of cells removed per mL per min 
per individual mussel. Note mussels were removed over the study:  21 mussels (day 0-
47), 15 mussels (day 47-67, and 9 mussels (67-107). Error bars reflect the standard error 
(SE) of the mean. 
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Growth in biomass also differed among treatment groups (ANOVA: F4, 20 = 5.2, P 
= 0.005; Table 2), with greater increases in biomass in controls [166.41 (SE 33.32) mg] 
than treatment [108.81 (SE 14.06) mg; Figure 2.3 B] groups. However, post-hoc Tukey 
test revealed there was no significant difference between controls and 0.3 ng/L treatment 
groups (P = 0.17). There was an effect of sample date (F2, 20 = 24.5, P < 0.001) and an 
interaction between sample date and treatment (F8, 20 = 2.4, P = 0.04), indicating the 
effect of fluoxetine on mussel biomass is dependent on exposure period, specifically with 
stronger effects after sample date 47 where the group means diverge. There was no 
difference in biomass change among mussels treated with 3 ng/L fluoxetine and those 
treated with 30 ng/L (P = 0.29) or 300 ng/L (P = 0.35).  
3. Body condition  
The gonadosomatic index (GSI) of mussels in control groups was much higher 
[28.3 (SE 3.6) GSI] than those treated with any concentration of fluoxetine [8.8 (SE 2.0) 
GSI; ANOVA: F4, 20 = 24.9, P<0.001, Figure 2.4 A].  There was only a marginal effect of 
sample date on mussel GSI (F2, 20 = 3.5, P= 0.05) and no 2nd order interactions (F8, 20 = 
1.2, P= 0.37). There were no differences in mean GSI among fluoxetine treatment 
groups. The condition index (CI) was also higher in controls than in treatment groups 
(ANOVA: F4, 20 = 5.6, P=0.001, Figure 2.4 B) and there was no difference among 
fluoxetine treatment groups. 
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Figure 2.3. Mussel growth as the increase in A) shell length (mm), and B) biomass (mg) 
across treatment groups over study period. Error bars reflect the standard error (SE) of 
the mean. 
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Figure 2.4. A) Gonadosomatic and B) condition indices for mussels on day 47, 67, and 
107 of the study. Error bars reflect the standard error (SE) of the mean. 
  
21 
 
Table 2.2. Results from Repeated measures ANOVAs, including all factors and 2nd order 
interactions. Clearance rate data underwent a Box-Cox transformation; other response 
variables were log-transformed. Treatment refers to fluoxetine concentration; sample date 
refers to subsample group; P-values <0.05 are shown in bold. 
 
Dependent Variable Factor  SS MS df F p 
Clearance rate Treatment 72.43 18.11 4 34.35 <0.001 
 Sample date 81.85 8.19 10 45.95 <0.001 
 Treatment*Sample date 21.20 0.53 40 2.96 <0.001 
 Error among groups 10.54 0.53 20   
 Error within groups 35.63 0.18 200   
       
Growth (length) Treatment 18.84 4.71 4 22.64 <0.001 
 Sample date 4.98 2.49 2 18.70 <0.001 
 Treatment*Sample date 0.70 0.09 8 0.65 0.73 
 Error among groups 4.16 0.21 20   
 Error within groups 5.33 0.13 40   
       
Growth (mass) Treatment 3.06 0.76 4 5.19 0.005 
 Sample date 4.61 2.31 2 24.53 <0.001 
 Treatment*Sample date 1.77 0.22 8 2.36 0.04 
 Error among groups 2.94 0.14 20   
 Error within groups 3.76 0.09 40   
       
Gondosomatic index (GSI) Treatment 21.22 5.31 4 24.93 <0.001 
 Sample date 1.49 0.74 2 3.51 0.05 
 Treatment*Sample date 2.09 0.26 8 1.23 0.37 
 Error among groups 3.45 0.17 20   
 Error within groups 9.32 0.23 40   
       
Condition index (CI) Treatment 4.97 1.24 4 5.6 0.001 
 Sample date 1.35 0.51 2 1.0 0.05 
 Treatment*Sample date 4.12 0.14 8 0.7 0.51 
 Error among groups 3.56 0.18 20   
 Error within groups 6.23 0.16 40   
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Discussion 
Our study demonstrates that prolonged exposure to nominal concentrations of 
fluoxetine impairs mussel physiology and function. We sampled mussels regularly over 
the exposure study to better understand how they respond to fluoxetine over time. Whole 
body metrics of fitness like growth in biomass and shell length were only affected over 
longer time periods. However, for parameters like the GSI and CI, fluoxetine exposure 
concentrations affected organisms by 47 days, without increasing differentiation over 
time. Our study builds on previous studies documenting fluoxetine’s effects on aquatic 
organisms by identifying organism-level and chronic exposure effects over several 
months (e.g., >100 days). By simulating chronic fluoxetine exposure in the laboratory, 
we offer a snapshot of how this single contaminant may impair mussels along rocky 
intertidal shorelines in the wild.  
Mussels like M. californianus regularly clear the water column of algae, suspended 
particles, and pollutants, improving water quality and providing a critical ecosystem 
function along coastal zones.  At locations where fluoxetine impairs mussel filter feeding, 
this important ecosystem function may be reduced.  Hazleton et al. (2014) conducted a 
67-day study with adult freshwater mussels, Lampsilis fasciola, exposed to four 
fluoxetine concentrations (0, 0.5, 2.5, and 22.3 µg/L), and assessed impacts on 
metabolism, movement, and filtering behavior. They found that mussels dosed with 2.5 
or 22.3 µg/L fluoxetine had increased activity levels when compared with controls, 
suggesting contaminated animals may be more susceptible to predators and reduced 
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energy storage, at least at higher fluoxetine concentrations. Increased activity levels (such 
as movement) in M. californianus may explain the reduced filtering function and slower 
growth rates. While we did not quantify movement patterns following Hazleton et al. 
(2014), we did observe that individual mussels exposed to 30 and 300 ng/L fluoxetine 
were more dispersed within the tanks and did not cluster as the controls and 0.3-3 ng/L 
treatment groups did. Hazelton and colleagues (2014) did not find clear differences 
between algal clearance rates but suggested observing clearance rates over shorter time 
periods (< 24 h). Our clearance trials were 3 h and we did see clear differences between 
control and treated groups. Further, after day 67 we observed that water clarity was 
qualitatively reduced in all 5 of the 300ng/L tanks suggesting that clearance was 
impaired.   
Because fluoxetine exposure impairs mussel clearance rates, it follows that energy 
storage and mussel growth would also be reduced (Bringolf et al. 2010; Hazelton et al. 
2014). Munari et al. (2014) exposed the clam Ruditapes phillippinarum to fluoxetine at 
six concentrations (0, 1, 5, 25, 125, 625 µg/L) for 7 days and found that haemocyte 
proliferation increased significantly in clams exposed to 25, 125, 625 µg/L, while gill 
acetylcholinesterase (AChE) activity decreased significantly in clams exposed to 1 or 5 
µg/L.  Their findings suggest that fluoxetine, at least at higher concentrations, strongly 
affects immune parameters and neurotransmission in clams. Franzellitti et al. (2014) 
reported similar effects with even lower concentrations of fluoxetine (e.g., 0.03-300 
ng/L), where fluoxetine reduced the health status of mussels in numerous cellular 
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biomarkers. Specifically, fluoxetine reduced the lysosomal membrane stability in 
haemocytes and caused accumulation of neutral lipids in the lysosomes of the digestive 
glands. We believe that the low condition index values of mussels treated with fluoxetine 
in our study are linked to similar cellular responses, although we quantified only 
organism-level metrics.  Similarly, we observed reduced growth in shell length and 
biomass in mussels exposed to fluoxetine above 3ng/L. After sample date 67, growth 
rates decreased for mussels exposed to 30 and 300 ng/L of fluoxetine (see slopes in 
Figure 2), suggesting that these concentrations have a stronger effect on growth. However 
these patterns would not be apparent from the typical short-term exposure studies of 30 
days or less. The findings demonstrate that responses measured over short time periods 
may miss the extent to which fluoxetine and other pharmaceutical compounds can affect 
marine organisms.  
In mussels, serotonin is involved in physiological and behavioral functions such as 
gill ciliary activity, oocyte maturation, and the induction of spawning (Stanley et al. 
2007; Bringolf et al. 2010; Fong & Ford 2014). Because fluoxetine regulates the reuptake 
of serotonin, it is likely the drug increases serotonin levels in mussels (Gibbons & 
Castagna 1984). Bringolf et al. (2010) found that fluoxetine accumulates in mussel 
tissues and has the potential to disrupt several aspects of reproduction in freshwater 
mussels. Despite their strong results, they recommended additional testing to evaluate the 
effects of long-term exposure to environmentally relevant concentrations. With our long-
term testing, the proportion of reproductive tissue to total tissue (GSI) was markedly 
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affected by fluoxetine after 47 days of exposure, a long time period among chronic 
exposure studies assessing reproduction. We hypothesize that fluoxetine is concentrated 
in mussel tissues over time resulting in a reduction of reproductive potential. A similar 
statement can be made about the CI, an assessment of the mussel’s overall health status. 
Overall, the energy invested into the gonad and somatic tissues was lower in mussels 
treated with fluoxetine than in controls.  
Fluoxetine is one of the most widely used antidepressants in the world (Metcalfe et al. 
2010). A robust amount of research has documented its occurrence in freshwater (Kwon 
and Armburst 2006; Ramirez et al. 2009; Bringolf et al. 2010; Corcoran et al. 2010) and 
marine (Kreke and Dietrich 2008; Vasskog et al. 2008) environments. Our study 
conditions mimic fluoxetine entering the environment in pulses, such as flushing from 
rain events, and organism exposure over time. The findings by Franzellitti et al. (2014) of 
the numerous adverse outcomes and fluoxetine bioconcentration at 30 and 300 ng/L 
exposure concentrations corroborate our results. Further, with growing human 
populations in coastal zones, increasing use of antidepressants like fluoxetine is expected, 
suggesting higher future concentrations in the marine environment.  
The results of this study serve as a foundation to understand how pharmaceuticals and 
other emerging contaminants are affecting marine species and community interactions. 
While we found fluoxetine to be a considerable stressor to marine mussels, it is only one 
of many stressors on marine organisms (Ankley et al. 2007; Boxall et al. 2009). 
Nearshore flora and fauna are exposed to a cocktail of contaminants, many of which (e.g., 
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sertraline (Effexor®; Bossus et al. 2013), carbamazepine (Tegretol®; Martin-Diaz et al. 
2009)) have negative effects on freshwater and marine organisms (e.g., Metcalfe et al. 
2010; Meredith-Williams 2012). Some studies have assessed pharmaceutical effects on 
animal behavior and their potential to alter species interactions (Gaworecki and Klaine 
2008; Bossus 2013; Hazelton et al. 2013). Yet, long-term studies examining effects of 
multiple compounds are warranted to understand interactive and cumulative organismal 
and potential ecosystem level effects (Brausch et al. 2012).  To our knowledge no studies 
have assessed community or ecosystem responses to pharmaceuticals or other emerging 
contaminants, an important step in understanding how these compounds may influence 
important inter- and intra-specific interactions. Finally, ecological studies are needed to 
assess how these compounds affect ecosystems in a changing world, considering 
interactive effects with ocean acidification and other impacts from climate change.  
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Chapter 3: Exposure to nominal concentrations of the pharmaceutical fluoxetine increases 
predation risk in the mud crab, Hemigrapsus oregonensis 
 
1. Introduction 
 
Predator-prey behavior dynamics are often regulated by a combination of abiotic 
and biotic factors (Holt and Lawton 1994; Abrams 2000; Grabowski 2004). Physical 
factors such as temperature, salinity, and photoperiod often limit where organisms can 
survive (e.g., fundamental niche), while species interactions such as competition, 
predation, or facilitation further restrict the spatial and temporal extent of an organism 
(e.g., realized niche; Hutchinson 1957; Lima & Dill 1990; De Roos et al. 2003; Chase et 
al. 2009). Animal behaviors are rooted within this realized niche wherein individuals 
modify their behaviors to balance risks (e.g., predation) with rewards (e.g., access to 
resources; De Roos et al. 2003, Brown and Kolter 2004). Often these risk-taking 
behaviors are plastic and change depending on the spatial (Morgan et al. 2006) or 
temporal (Miller & Morgan 2015) conditions (Snell-Rood 2013). Ecologists are eager to 
understand animal behaviors to more accurately predict population-, community-, or 
landscape-level processes (Abrams 2000; Shochat et al. 2006; Sih et al. 2012; Balke et al. 
2014).  
Yet, there is a growing list of human-driven impacts that alter animal behavior, 
setting additional boundaries on an animal’s realized niche (Barros 2001; Frid & Dill 
2002; Fahrig 2007; Dodd et al. 2015). Fisheries have historically removed large 
  
28 
 
predators, modifying community behaviors through release from predation pressure 
(Myers & Worm 2003; Catano et al. 2015). Anthropogenic noise pollution in the ocean 
has been shown to alter the behaviors of numerous marine mammals (Nowacek et al. 
2007). Ocean acidification alters development of larval fishes, disrupting their ability to 
detect predator cues and leading to increased mortality (Munday et al. 2010). Exposure to 
heavy metals, pesticides, petroleum and other legacy contaminants affect animal 
behaviors by altering habitat preference, shifting migration patterns, or increasing 
negative species interactions (Fleeger et al. 2003; Khoury et al. 2009; Eades & Waring 
2010; Fukunaga et al. 2010). Such alterations to normal behaviors have been linked to 
reduced fitness, and changes to population structure and ecosystem function (Frid & Dill 
2002; Fahrig 2007; Ings et al. 2009).  
Much less studied are the effects of pharmaceuticals and other emerging 
contaminants on animal behavior, despite frequent detections of these compounds in the 
marine environment (Boxall et al. 2012; Brausch et al. 2012; Gaw et al. 2014). 
Pharmaceutical compounds and their derivatives regularly enter estuaries and nearshore 
coastal ecosystems via transport of contaminated surface and groundwater runoff, 
suspended river sediments, and untreated sewage effluent (Metcalfe et al. 2010; Bringolf 
et al. 2010; Khairy et al. 2014). As medical drugs, these compounds are designed to illicit 
biological responses and could have considerable effects on organism health, despite 
detections at low concentrations (Seiler 2002; Ankley et al. 2007). Prolonged studies on 
marine organisms at environmentally relevant concentrations are lacking (Berninger & 
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Brooks 2010; Gaw et al. 2014).  Most pharmaceutical exposure studies are rooted in 
ecotoxicological methodology focused on adverse outcomes at the cellular or subcellular-
level (Boxall et al. 2012). Exposure studies that assess the effects of pharmaceuticals on 
whole-organism effects, and multi-organism or community-level interactions are needed 
to improve ecological inferences and predictions (Fleeger et al. 2003; Brooks et al. 2009; 
Corcoran et al. 2010; Gaw et al. 2015).  
Mesocosm and tank experiments are often used to assess animal behavior 
responses to stressors, particularly when the stressor cannot be controlled in the field. 
These include studies where different combinations of stressors such as chemical cues, 
temperature, or pH are manipulated in order to measure the behavioral response (Munday 
et al. 2009; Dodd et al. 2015). Pharmaceutical contaminants as stressors require a similar 
approach to determine if detected or projected concentrations affect organism behaviors 
(Hellou 2011; Mesquita et al. 2011; Lazzara et al. 2012; Maranho et al. 2015). Relatively 
few studies have assessed how pharmaceuticals affect interspecific behaviors such as 
predator-prey interactions (Brodin et al. 2014; Gaw et al. 2014).  Yet several studies have 
demonstrated alterations in behavior that could lead to increased predation and mortality 
(Corcoran 2010; Schultz et al. 2011; Hazelton et al. 2013; Brodin et al. 2014).   
Selective serotonin reuptake inhibitor (SSRI) anti-depressants such as fluoxetine 
hydrochloride (Prozac®) are among the more prevalent categories of pharmaceuticals 
detected in the marine environment (Kreke and Dietrich 2008; Vasskog et al. 2008; 
Brodin et al. 2014; Gaw et al. 2014). SSRIs have been developed to delay the reuptake of 
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serotonin, moderating neurotransmission in the human brain. In crustaceans, serotonin is 
well known to affect behaviors through stimulating the release of hyperglycaemic, 
neurodepressing, moult-inhibiting, and gonad-stimulating hormones (Fong and Ford 
2014). McPhee and Wilkens (1989) found that Carcinus maenas injected with serotonin 
displayed increased activity levels during the day, whereas normally they are 
photonegative with increased activity at night. In the same crab species, fluoxetine 
significantly altered locomotor behaviors at 120 μg/L (Mesquita et al. 2011).  Several 
other studies have demonstrated that fluoxetine leads to adverse physiological and 
behavioral outcomes in aquatic organisms that could alter their functional roles within the 
community (Perreault et al. 2003; Lynn et al. 2007; Stanley et al. 2007; Mennigen et al. 
2010; Schultz et al. 2011; Dzieweczynski & Herbert 2012; Kohlert et al. 2012; Bossus et 
al. 2013; Barry 2013; Munari et al. 2014; Chen et al. 2015).   
Using a controlled laboratory set up, we designed a study to assess the behavior of 
the mud crab, Hemigrapsus oregonensis, following exposure to the pharmaceutical 
contaminant, fluoxetine. Fluoxetine has been frequently detected in coastal areas at low 
concentrations (0.03ng/L -300 ng/L) and is considered toxic to fish and marine 
invertebrates (Brooks et al. 2003). In our study, aquarium habitats were designed to 
emulate estuarine conditions to assess alterations of H. oregonensis behaviors under the 
influence of fluoxetine at controlled concentrations (3 and 30ng/L). We conducted 
diurnal and nocturnal behavior trials to assess whether fluoxetine altered the risk-taking 
behaviors of H. oregonensis in response to a predator, the red rock crab Cancer 
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productus. Our study is one of the few studies to assess how pharmaceutical 
contaminants may affect risk-taking behavior in marine animals. 
  
2. Material and methods 
2.1. Study Animals 
The Oregon mud crab, Hemigrapsus oregonensis (Dana, 1851; Figure. 1A), is a 
small intertidal shore crab belonging to the family Grapsidae, and is one of the most 
common species inhabiting estuarine shorelines between Resurrection Bay, Alaska and 
Bahia de Todos Santos, Baja California.  They forage mostly at night, with a diet 
consisting primarily of diatoms and green algae, but they will eat carrion and other meat, 
if available (Lindberg 1980). H. oregonensis spend most of their time on, beneath, or near 
rocks in gravel and fine sediment substrate. To escape predators, H. oregonensis often 
quickly burrow in mud or hide beneath rocks; they also rely on camouflage while 
remaining motionless (Lindberg 1980). Because H. oregonensis inhabit the soft 
sediments of estuaries, they are likely exposed to contaminants, including fluoxetine; in 
estuaries, fluoxetine concentrations have been detected as high as 30ng/L (Franzellitti et 
al. 2014). For this reason, I chose these crabs as a model organism for fluoxetine 
exposure during behavioral trials.   
Red rock crabs, Cancer productus (Randall, 1839; Figure 3.1 C), are one of 
several Cancer species that inhabit the Pacific Coast of North America, occupying a 
similar range as H. oregonensis.  They range from sub- to intertidal habitats, but will 
regularly occur in estuarine habitats during high tide (McGraw 2005). They regularly 
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prey on barnacles, amphipods, intertidal invertebrates, and smaller crabs, including 
Hemigrapsus spp. I chose C. productus as my model predator because of its overlapping 
range at high tide, whereby the predator may enter an estuary contaminated with 
fluoxetine and encounter prey species such as H. oregonensis.  
 
2.2. Experimental holding conditions  
H. oregonensis and C. productus crabs were collected from a single location 
along an estuarine shoreline in Netarts Bay, Oregon (45°24’51.21”N, 123°56’4.38”W) on 
June 15, 2015. C. productus were caught using crab traps deployed at high tide while H. 
oregonensis were hand captured along the edge of the shoreline.  Both species were 
transported in chilled seawater to the laboratory at Portland State University.  Upon 
arrival, H. oregonensis (n= 90) were sorted, measured, and randomly distributed into 30 
housing tanks (~64 L, 3 crabs in each). C. productus (n= 15) were sorted into three 
designated housing tanks (~120 L, 5 in each) to prevent cross contamination following 
exposure to fluoxetine during behavioral trials.  Each housing tank had an independent 
water chilling and filtration system (Aquatic Enterprises). Seawater was prepared using 
Instant Ocean® and deionized water; salinity and temperature were maintained at 35 PSU 
and 16.0 °C to replicate conditions at the collection site.  To reduce buildup of animal 
waste products, 20% of the seawater was replaced with fresh seawater every 20 days. I 
monitored water chemistry (i.e., ammonia, pH, nitrate, and nitrite) every two weeks to 
ensure levels were appropriate for crabs. Water criterion was adequate each time.  Light 
cycle conditions were maintained at 10 h of dark and 14 h of daylight. Animals were 
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allowed to acclimate to aquarium habitats (Figure 3.1 A and B) and laboratory conditions 
for 2 weeks before the exposure study began. During the acclimation period, crab health 
and condition were monitored. A total of 8 H. oregonensis died during acclimation and 
were immediately replaced with one of the extra crabs of the same gender and size class 
from the original collection. During the exposure study (60 days), 31 crabs perished 
either through predation by C. productus during trials (n=18) or through conflicts 
between conspecifics (n=13), in which case each was immediately replaced by an 
individual of the same size class and gender.   
Every two days, H. oregonensis were fed a diet of either squid or shrimp pieces. 
In addition, H. oregonensis regularly grazed algae from rocks and sediment and filter fed 
by rapidly beating their third maxillipeds near their mouth. C. productus were fed squid 
every 2 days. At the end of the study I sacrificed all H. oregonensis, and quantified the 
number of appendages lost as a proxy for aggression among conspecifics.  
2.3. Experimental design  
The experiment followed a repeated measures design in which the tank was the 
subject measured at each time point (day vs. night periods, with vs. without predators, 
and multiple times for each period and trial type) and was nested within the between-
measures factor, fluoxetine treatment. The fluoxetine treatments consisted of 3 
concentrations: 0, 3, and 30 ng/L which are the range detected in estuarine and harbor 
waters (Kreke and Dietrich 2008; Vasskog et al. 2008). Each treatment group was 
comprised of 10 replicates. Each fluoxetine treatment concentration (3.0 and 30.0 ng/L) 
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was reached using separate dosing solutions prepared through serial dilution of the 
original stock solution of 1.0 mg/mL fluoxetine hydrochloride (Sigma-Aldrich) dissolved 
in nanopure water.  Every 10 days, tanks were dosed by spilling 193µL of the appropriate 
fluoxetine dosing solution into each tank. Controls without fluoxetine received 193µL of 
nanopure water on dosing days.  
Three H. oregonensis were assigned to each tank, with 1 dominant male, 1 
subordinate female, and 1 subordinate male. While we recorded the behavior of each 
animal, our experimental units were the individual tanks (n=30) with 10 replicate tanks 
nested within each treatment group.  Weekly behavioral trials were our observational 
units, where all animals in each tank were observed for one-hour periods at day and night 
times, both with and without predators present (4 trial types over 9 weeks, n=36). No-
predator trials were used as a reference for assessing behaviors without any perceived 
threats.  
2.4. Behavioral Trials  
 Housing tanks were designed to simulate the estuarine conditions from which H. 
oregonensis were collected. Each tank was filled with sand (500g) and small pebbles 
(500) for burrowing substrate and one large rock (600-750g) to hide under (Fig. 1c). 
Tanks were assembled on 3 racks (10 tanks per rack) with sides between tanks blacked 
out with plastic lining to maintain behavioral isolation. Each tank contained 3 H. 
oregonensis: 1 large dominant male (mean carapace width (CW) ± SE = 25.54 ± 0.42 
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mm; mean biomass ± SE = 9.3 ± 1.4 g), 1 small female (CW = 19.25 ± 0.74 mm; 3.6 ± 
1.5 g), and 1 small male (21.29 ± 0.65; 4.97 ± 0.97 g). Mean size of crabs did not differ 
among treatments or tanks (one-way ANOVA, P > 0.4 in both cases). This density of 
crabs (3.0 / 30 cm2) is within the natural range of H. oregonensis densities at the 
collection site (densities as high as 20 crabs/50 cm2 were observed). We kept crab 
densities low to allow enough space for escape from the much larger C. productus (range: 
100 to 150 mm CW) during predator addition trials.  
Hour-long trials were recorded using ethograms with common crab behaviors 
outlined for each animal. These behaviors were organized by category: Still, active, 
foraging, aggression, non-aggression, avoidance, and predator avoidance behaviors. Still 
behaviors included: buried, unmoving, moving mandibles only. Active behaviors 
included: walking, digging, swimming and moving in place. Foraging behaviors were 
those where crabs were probing, handling, or eating food. Aggression, non-aggression, 
and avoidance behaviors were defined as interactions between conspecifics such as 
fighting, charging, mating, or avoiding one another.  Predator avoidance behaviors were 
interspecific, where H. oregonensis displayed escape or non-escape behaviors in the 
presence of C. productus. We also noted the number of H. oregonensis captured or killed 
by C. productus.  
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Figure 3.1. Pictures of A) an Hemigrapsus oregonensis in the aquarium habitat, B) 
example of the tank set up with sides blacked out, C) addition of Cancer productus 
during predator trials, and D) an observer recording crab behavior during a night trial. 
 
Following procedures outlined by Altmann (1974) observers recorded the 
behavioral acts of all individuals in each tank via instantaneous scan sampling at 5 min 
intervals for 1 hour. Scans lasted 30 seconds, allowing the observer to record acts of 
individuals in 10 tanks before returning to the first tank for the next interval. A total of 12 
acts were recorded for each animal during the hour period.  Day trials were conducted 
from 10:00-11:00 am and night trials were conducted from 7:00-8:00pm. During night 
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trials, we used red LED lights to record observations while avoiding the effects of visible 
light wavelengths on nocturnal behaviors (Figure 3.1.D). No-predator trials for both day 
and night trials preceded predator trials by 24 hours with 80 hours in between each 
week’s two predator trials to allow crabs to recuperate.  All trials were conducted from 
June 29 to August 27, 2015. 
 
2.5. Statistical Analysis  
Ethograms from the trials were analyzed for crab behavior and predation risk. I 
assessed the effect of fluoxetine treatment on H. oregonensis diurnal and nocturnal 
behaviors by examining the differences in the proportions of active, foraging, agonistic, 
and predator avoidance behaviors in trials with and without predators. To determine these 
proportions, I a priori divided active behaviors (i.e., walking, digging, and interactions 
between conspecifics) and non-active behaviors (i.e., remaining still, buried, or just 
moving mandibles); foraging and non-foraging behaviors; as well as agonistic and non-
agonistic behaviors. Predator avoidance behaviors were also a priori determined as 
remaining buried, still, or retreat under rock/elsewhere in tank and non-avoidance 
behaviors as remaining active, foraging, or interacting without response to the predator. 
Within each trial type (no predator/predator) and time of day (day/night) I tested 
whether the effect of fluoxetine treatment on behavioral proportions varied across crab 
sex and gender. Specifically, I tested the probability of successfully exhibiting behavioral 
acts using mixed-effect generalized linear models (GLMM) fitted with a binomial error 
distribution using the glmer function in the lme4 package (Bates et al., 2015) in R Studio 
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(R Core Team, 2015).  Behavioral proportional data was over-dispersed, indicating a 
need to fit the logistic regression with a random intercept (the 30 individual housing 
tanks). The random effect of the tanks accounts for variance structure between 
observations made on the same animals overtime. A separate GLMM was fitted to each 
behavior in question (i.e. active, foraging, agonistic, and predator avoidance) to 
determine if the effect of fluoxetine treatment varied among crab gender and status. In all 
GLMMs the proportional data underwent logit transformation to ensure normality and 
homoscedasticity of the residuals. 
For behavioral GLMMs, I added components to the null model (i.e., random 
intercept) stepwise to determine if they improved the model fit based on Akaike 
information criterion (AIC). Components that significantly benefitted the full model fit 
included: fluoxetine treatment groups and crab gender and status. In all models, the 
length of fluoxetine exposure (in weeks) was not significant (likelihood ratio test, LRT, P 
> 0.3 in both cases) so exposure time was not included.  Post hoc multiple comparisons 
of the models were generated using the multcomp package in R (Hothorn et al. 2008). 
 
3. Results 
Active behaviors 
The effect of fluoxetine on H. oregonensis active behaviors varied across trial 
types and time of day (glmer, likelihood ratio test (LRT), χ2 (2) = 292.31, P < 0.0001, 
Figure 3.2). A crab exposed to 30 ng/L of fluoxetine had the highest probability of 
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exhibiting active behaviors when predators were absent at night (predicted probability of 
active behavior =0.79) and during the day (0.68). When predators were present the 
probabilities declined for both time periods (0.62, 0.60, respectfully).  
During the day when predators were not present, fluoxetine affected H. 
oregonensis (χ2 (2) = 23.78, P < 0.001, Figure 3.2), increasing the proportion of active 
behaviors when exposed to 30 ng/L of fluoxetine (estimate ± SE; 1.23 ± 0.27, P <0.001). 
The effect of 3ng/L and control groups on active behaviors were negative (-1.37 ± 0.19 
and -0.29 ± 0.27, respectively), indicating that crabs in these treatments spent a greater 
proportion of their time being still relative to the 30ng/L group.).  Crab gender and status 
did not significantly explain the variation of active behaviors alone (χ2 (2) = 4.73, P 
=0.09), however the interaction between fluoxetine treatment and crab gender and status 
significantly improved the model fit (χ2 (6) = 72.95, P <0.001).  Dominant males were 
more active than females and subordinate males (estimate 0.44 ± 0.11 vs. -0.09 ± 0.11 
and -1.50 ± 0.20, P <0.001 in both cases). However subordinate males were more active 
when exposed to 30 ng/L of fluoxetine compared with controls (P=0.02).  
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Figure. 3.2. Proportions of H.oregonensis day and night behaviors by gender, status, and 
fluoxetine treatment when no predators are present.  Circles indicate proportions (yellow 
= active, red = agonistic, blue = foraging); genders (M/F); status (Dom=dominant, 
Sub=subordinate).  
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Foraging behaviors 
Fluoxetine exposure affected foraging behaviors as well (χ2 (2) = 13.77, P 
=0.001), although this effect was mediated by the gender and status of the crab (χ2 (6) = 
82.68, P <0.001). Dominant males and subordinate females in 30ng/L spent a greater 
proportion of time foraging during the day than their counterparts in control groups 
(P<0.01, in both cases), however subordinate males did not differ significantly (P=0.22).  
Fluoxetine had a strong effect on nocturnal foraging behaviors (χ2 (2) = 8.21, P = 0.02). 
Both dominant and subordinate males exposed to 30 ng/L of fluoxetine significantly 
increased their foraging behaviors at night (P<0.001, P=0.001, respectively), however in 
females there was no treatment effect (P>0.5, in all cases). 
Agonistic behaviors 
Crab aggression varied across treatment combinations and time of day (χ2 (8) = 
18.63, P = 0.002). The proportion of aggressive acts among H. oregonensis was low 
across all treatments (range: 0.008-0.03), but crabs exposed to 30 ng/L fluoxetine were 
predicted to have the highest probability of aggressive behavior (0.03) compared to 
0.3ng/L (0.01) and control crabs (0.008). Post-hoc Tukey contrasts indicated significant 
differences between controls and 30ng/L treatment groups (P < 0.001 in all cases). 
Controls and 0.3ng/L groups only differed when the predator was added (P= 0.007), 
where 0.3ng/L crabs exhibited slightly more aggressive behaviors (0.005) than the 
controls (0.0002, Figure 3.3). Nocturnal agonistic behaviors were higher than diurnal 
agonistic behaviors yet were also affected by fluoxetine (χ2 (2) = 20.27, P <0.001).  
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Figure. 3.3. Proportions of H.oregonensis day and night behaviors by gender, status, and 
fluoxetine treatment when predators are present.  Circles indicate proportions (yellow = 
active, red = agonistic, blue = foraging); genders (M/F); status (Dom=dominant, 
Sub=subordinate).  
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Predator avoidance behaviors 
Predator avoidance behavior also varied across treatments and time of day (χ2 (8) 
= 220.17, P < 0.0001, Figure 3.3).  Control crabs were most likely to avoid predators 
during the day (predicted probability of predator avoidance = 0.92) and at night (0.75) 
compared to crabs exposed to 3 ng/L (0.61 during the day; 0.57 at night), or 30 ng/L of 
fluoxetine (0.37 during the day; 0.40 at night). When predators were added during the 
day, crabs generally decreased active, foraging, and agonistic behaviors. However, crabs 
treated with 30 ng/L did not show a significant decrease in these behaviors when 
compared with 3 ng/L and control groups (χ2 (2) = 43.78, P < 0.001, Figure 3.2). 
Fluoxetine exposure had a strong negative effect on predator avoidance behaviors despite 
crab gender or status (LRT, d.f. = 7, 9, χ2 = 51.11, P < 0.0001). However the predator 
avoidance behaviors of males were more affected by fluoxetine exposure than for females 
(See Figure 3.2. for a list of proportions of predator avoidance behaviors by gender and 
status).  More crabs were captured and predated upon by C. productus in the 30 ng/L 
treatment group (n=8) than in the control and 3 ng/L groups (n=5 in each). Neither 
predator avoidance nor active behaviors varied over time (lm, F1,21=2.5, P = 0.23; 
F1,21=1.5, P=0.23, respectively).  
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Table. 3.1. Mean proportions of H. oregonensis predator avoidance behaviors (± SE) by 
fluoxetine treatment and time of day. Arranged by crab gender (♂/♀) and status 
(dominant = Dom/subordinate = Sub).  
 
Day Night 
Control 
Dom ♂ 0.91 ± 0.01 0.69 ± 0.04 
Sub ♂ 0.89 ± 0.02 0.76 ± 0.02 
Sub ♀ 0.81 ± 0.02 0.61 ± 0.04 
3.0 ng/L 
Dom ♂ 0.57 ± 0.02 0.57 ± 0.04 
Sub ♂ 0.64 ± 0.03 0.67 ± 0.02 
Sub ♀ 0.57 ± 0.03 0.45 ± 0.04 
30.0 ng/L 
Dom ♂ 0.41 ± 0.03 0.41 ± 0.03 
Sub ♂ 0.42 ± 0.02 0.36 ± 0.03 
Sub ♀ 0.41 ± 0.02 0.37 ± 0.03 
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Figure. 3.4. Proportions of H. oregonensis day and night behaviors by gender, status, and 
fluoxetine treatment representing the difference between no predator and predator trials 
(i.e., the predator effect).  Circles indicate proportions (yellow = active, red = agonistic, 
blue = foraging); genders (M/F); status (Dom=dominant, Sub=subordinate). Points above 
the line indicate scenarios in which a behavior was greater in the presence of a predator. 
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4. Discussion 
 
In the presence of predators, prey will often modify their behaviors to balance the 
risk of mortality with the reward of accessing food, mates, or other resources (Weis 2010; 
Sih et al. 2012; Snell-Rood 2013; Catano et al. 2015). Prey may reduce their activity 
levels, utilize defenses, or seek refuge when they perceive the risk to be high (Lindberg 
1980, Lima & Dill 1990; Preisser et al., 2007). We assessed whether the risk-taking 
behaviors of H. oregonensis would be altered under the influence of fluoxetine, a 
pharmaceutical contaminant commonly detected in estuaries and harbor waters (Kwon 
and Armburst 2006; Kreke and Dietrich 2008). Crabs exposed to the highest level of 
fluoxetine were more likely to be active and exhibit risk-taking behaviors in the presence 
of C. productus, resulting in a greater probability of predator capture and mortality. In 
fact, more crabs were captured by C. productus in the higher fluoxetine treatment than in 
the 3 ng/L or control treatments. Crabs in control groups exhibited a greater probability 
of predator avoidance behaviors because they reduced their activity levels and/or actively 
sought refuge when the predator was an immediate threat. Our results suggest that 
fluoxetine stimulates crab activity levels and reduces their inhibition to predator threats. 
For crabs inhabiting harbors or estuaries contaminated with fluoxetine, the changes to 
their normal behaviors may place them at greater risk of injury and mortality, with 
potential community-level effects.  
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I designed this experiment to simulate estuarine conditions in the laboratory, 
whereby H. oregonensis could reside in a similar habitat while exhibiting somewhat 
natural behaviors. I controlled between tank variation by maintaining identical abiotic 
conditions (e.g., light, temperature, salinity) and habitat substrate (e.g., rocks, gravel, and 
sand) across treatments. Therefore I propose that the differences in crab behavior 
reported here were attributable to fluoxetine rather than experimental artifacts. The 59 
crabs that survived until the end of the trials (60 days) were likely overexposed to crab 
predators although we did not see a pattern of learned tolerance of predator presence. We 
believe any learned tolerance was minimal because 1) we allowed for sufficient time 
between predator trials (i.e., 80 hours); 2) we did not preclude C. productus from 
predating on H. oregonensis during the trials; and 3) predator induced mortality did not 
decline over time. Further, our observed proportions of crab active and predator 
avoidance behaviors did not change significantly over the length of the study, which we 
would expect if H. oregonensis learned to not perceive C. productus as a threat. Rather, 
the variability in H. oregonensis risk-taking behaviors remained fairly low across 
treatments during predator trials (see mean proportions by week in Figure 3.3).   
Our predictive models were best fit by the interactions between treatment 
combinations and time of day, which suggests that crab behavior was mediated by 
photoperiod.  Like other crabs, H. oregonensis are photonegative, increasing activity 
levels and foraging primarily at night. Assuming crabs in control groups serve as a 
reference, exhibiting the most ‘typical’ behaviors, we would expect higher activity 
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amongst all crabs during night trials. However, crabs exposed to 30 ng/L-spiked water 
exhibited twice as much active behavior at night as control groups, suggesting a strong 
effect of fluoxetine.  Interestingly, there was little difference between diurnal and 
nocturnal activity levels in crabs exposed to 3ng/L of fluoxetine. Perhaps photoperiod 
was not as important for regulating activity in this treatment group, since predator 
avoidance behaviors were also low. From our observations, crabs in this group appeared 
to be the least affected by the addition of the crab predator, as evidenced by the lack of 
behavioral alterations between trial type (Figures 3.2. and 3.3).   
Serotonin and serotonin analogs have been shown to alter agonistic behaviors 
(McPhee & Wilkens 1989; Tierney & Mangiamele 2001) and activity levels (Perez-
Campos et al. 2012; Fong & Ford 2014) in crustaceans. Fluoxetine in concentrations 
equal or greater than 120µg L-1 caused a stimulation of locomotor behavior in the crab 
Carcinus maenas (Mesquita et al. 2011). We found similar increases in agonistic 
behaviors of crabs exposed to 30ng/L of fluoxetine, but with much lower exposure 
concentrations than in Mesquita et al. (2011). In Chasmagnathus crabs, Pedetta et al. 
(2008) modulated the individual aggressiveness via manipulation of serotonin and 
octopamine levels, where aggressiveness increased and decreased with the addition of the 
respective hormone.  Perhaps fluoxetine, through modulation of serotonin levels, 
stimulates crab activity levels and drives the observed aggressive behaviors. Further, our 
results demonstrate that fluoxetine may inhibit predator avoidance behaviors. The drug’s 
effect on serotonin levels appears to increase boldness and potentially other risk taking 
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behavior as studies on other species have suggested (Tierney & Mangiamele 2001; 
Pedetta et al. 2010; Mesquita et al. 2011; Dzieweczynski & Herbert 2012; Fong & Ford 
2014).  
Fluoxetine is one of the most widely used antidepressants in the world (Metcalfe 
et al. 2010). A robust amount of research has documented its occurrence in aquatic 
(Kwon and Armburst 2006; Ramirez et al. 2009; Bringolf et al. 2010; Corcoran et al. 
2010) and marine (Kreke and Dietrich 2008; Vasskog et al. 2008) environments. With 
growing human populations in coastal zones, increasing use of antidepressants like 
fluoxetine is expected, suggesting higher future concentrations in the marine 
environment. Our results demonstrate how pharmaceuticals and other emerging 
contaminants may affect species behaviors and their interactions. Brodin et al. (2014) 
summarized several ecologically important behavioral traits for assessing sublethal 
effects of pharmaceutical exposure, and potential direct or indirect ecological effects. 
These behavioral traits include: activity, aggression, boldness, exploration, and sociality. 
Each of these behavioral traits lead to direct ecological effects such as cooperation, 
dispersal/migration, feeding rates, mating success, parental care, and predator avoidance. 
These direct effects can be linked to differences in community structure, cross-boundary 
effects, ecosystem function, feedback loops, population dynamics, and trophic cascades. 
Anthropogenic impacts to coastal systems such as ocean acidification, warming surface 
water temperatures, and pollution have all been identified as significant environmental 
stressors, altering much of the aforementioned ecosystem processes (Munday et al. 2009; 
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Fukunaga et al. 2010; Dodd et al. 2015). Since pharmaceuticals have been shown to 
affect many of the same processes through similar mechanisms, they warrant 
consideration as an important environmental stressor in need of further research.  
Estuarine and coastal organisms are exposed to whole suites of contaminants, 
many of which (e.g., sertraline (Effexor®; Bossus et al. 2013), carbamazepine 
(Tegretol®; Martin-Diaz et al. 2009)) have negative effects on aquatic and marine 
organisms (e.g., Metcalfe et al. 2010; Meredith-Williams 2012; Gaw et al. 2014; Fong & 
Ford 2014). Our study and others have assessed the effects of single pharmaceuticals on 
animal behavior and their potential to alter species interactions (Gaworecki and Klaine 
2008; Bossus 2013; Hazelton et al. 2013). Yet, additional studies examining the effects of 
multiple compounds are warranted to understand interactive and cumulative effects on 
organisms and ecosystems (Brausch et al. 2012; Brodin et al. 2014).  Further, studies that 
assess how pharmaceuticals interact with lower pH (i.e., ocean acidification conditions) 
would add to the growing field of multiple stressor research. To our knowledge no 
studies have assessed community or ecosystem responses to pharmaceuticals or other 
emerging contaminants, an important step in understanding how these compounds may 
influence important inter- and intra-specific interactions. Finally, it would be 
advantageous for both ecology and ecotoxociology to merge components of 
pharmaceutical contaminants research, as both disciplines use similar species and 
examine similar endpoints while addressing separate questions. If we are to truly 
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understand how pharmaceuticals may act as stressors to marine ecosystems, we need to 
learn from the collective work in this emerging field.  
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Chapter 4: Conclusions 
 
This case study of fluoxetine builds on previous studies documenting fluoxetine’s 
effects on aquatic organisms by identifying the chronic exposure effects (47-107 days) on 
organism health, behavior, and functioning. The results from the two different 
experiments indicate that fluoxetine is a considerable environmental stressor, even at the 
low concentrations detected in the marine environment. Specifically, nominal 
concentrations of fluoxetine significantly affect both mussel and crab physiology and 
behavior, which may negatively affect individual fitness and species interactions. While 
both studies involve only one or two species, the implications of the results suggest that 
fluoxetine exposure could affect community- or ecosystem-level processes. By 
simulating chronic fluoxetine exposure in the laboratory we offer a snapshot of how this 
single contaminant may serve as an environmental stressor to invertebrates along rocky 
intertidal and estuarine shorelines in the wild.  
Fluoxetine is one of the most widely prescribed antidepressants in the world and a 
significant amount of research has documented its occurrence and negative effects on 
organisms in aquatic and marine environments. With growing human populations in 
coastal zones, increasing use of antidepressants, like fluoxetine, is expected, suggesting 
higher future concentrations in the marine environment. We have demonstrated that 
fluoxetine reduces M. californianus algal clearance rates, growth, and reproductive 
potential at very low concentrations. We also found that similar low concentrations 
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increased predation susceptibility by stimulating activity levels and risk-taking behaviors 
in H. oregonensis. For mussels and crabs inhabiting harbors or estuaries contaminated 
with fluoxetine, the changes to their normal behaviors and functioning may yield 
community-level consequences.   
The results of this study serve as a foundation to understand how pharmaceuticals 
may act as emerging environmental stressors, affecting marine species and their 
interactions. While we found fluoxetine to be a considerable stressor to marine mussels 
and crabs, it is only one of many stressors on marine organisms. Other studies have 
assessed how individual pharmaceuticals may affect animal behavior and health, and 
their potential to alter species interactions. These collectively fill important data gaps 
with respect to emerging contaminant research. However, long-term studies examining 
the effects of multiple stressors, such as multiple pharmaceuticals or the combination of 
pharmaceuticals with ocean acidification or other pollutants, are warranted to understand 
interactive and cumulative organism and potential ecosystem level effects.  
Finally, ecology and ecotoxicology, the two primary disciplines that assess impacts 
from pharmaceutical as environmental stressors, need to integrate their research.  The 
advantage of combining the findings from these two research fields is evident, as 
pharmaceuticals in the environment often modify important ecosystem processes. This 
project attempts to bridge the two fields by providing data from a hybridized 
methodology that combined standardized ecotoxicology testing with ecological 
questioning.  
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Appendix A.  Table of mussel metrics organized by mean ± SE and fluoxetine treatment 
group. Total biomass was the aggregate wet biomass of mussels per tank (n = number of 
mussels). 
Fluoxetine 
Treatment 
Initial Length 
(mm) 
Initial Mass 
(g) 
Total Biomass (g)        
n =21 
Total 
Biomass (g)         
n = 15 
Total 
Biomass (g)  
n = 9 
Control 32.67 ± 0.31 4.39 ± 0.14 90.33 ± 1.26 63.11 ± 1.33 34.02 ± 1.30 
0.3 ng/L 32.55 ± 0.44 4.18 ± 0.11 86.95 ± 0.71 59.61 ± 1.29 35.36 ± 0.63 
3 ng/L 31.78 ± 0.32 4.02 ± 0.14 84.15 ± 1.14 59.95 ± 1.30 35.28 ± 1.64 
30 ng/L 31.58 ± 0.36 4.03 ± 0.12 84.12 ± 1.66 56.38 ± 0.51 33.24 ± 0.98 
300 ng/L 32.53 ± 0.32 4.33 ± 0.14 90.15 ± 1.06 63.32 ± 1.00 36.46 ± 1.30 
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Appendix B. Mussel growth (length) multiple comparison tests by treatment group and 
sample date. P-values adjusted by Bonferroni correction.   
Pairwise comparisons Estimate Standard Errror  Z - value P ( > | Z | ) 
G
ro
w
th
 (
le
n
g
th
) 
Control_67 - 300_67 == 0 1.181 0.252 4.697 <0.01 
Control_67 - 30_67 == 0 0.684 0.252 2.720 0.290 
Control_67 - 3_67 == 0 0.257 0.252 1.022 1.000 
Control_67 - 0.3_67 == 0 0.166 0.252 0.660 1.000 
Control_47 - 300_47 == 0 1.303 0.252 5.181 <0.01 
Control_47 - 30_47 == 0 1.181 0.252 4.695 <0.01 
Control_47 - 3_47 == 0 0.299 0.252 1.190 0.997 
Control_47 - 0.3_47 == 0 0.442 0.252 1.757 0.913 
Control_107 - 300_107 == 0 1.493 0.252 5.938 <0.01 
Control_107 - 30_107 == 0 1.166 0.252 4.635 <0.01 
Control_107 - 3_107 == 0 0.289 0.252 1.149 0.998 
Control_107 - 0.3_107 == 0 0.234 0.252 0.932 1.000 
300_67 - 30_67 == 0 -0.497 0.252 -1.977 0.810 
300_67 - 3_67 == 0 -0.924 0.252 -3.674 0.019 
300_67 - 0.3_67 == 0 -1.015 0.252 -4.037 <0.01 
300_47 - 30_47 == 0 -0.122 0.252 -0.486 1 
300_47 - 3_47 == 0 -1.004 0.252 -3.991 <0.01 
300_47 - 0.3_47 == 0 -0.861 0.252 -3.424 0.045 
300_107 - 30_107 == 0 -0.328 0.252 -1.303 0.994 
300_107 - 3_107 == 0 -1.204 0.252 -4.788 <0.01 
300_107 - 0.3_107 == 0 -1.259 0.252 -5.006 <0.01 
30_67 - 3_67 == 0 -0.427 0.252 -1.698 0.933 
30_67 - 0.3_67 == 0 -0.518 0.252 -2.060 0.759 
30_47 - 3_47 == 0 -0.881 0.252 -3.504 0.034 
30_47 - 0.3_47 == 0 -0.739 0.252 -2.938 0.176 
30_107 - 3_107 == 0 -0.877 0.252 -3.486 0.037 
30_107 - 0.3_107 == 0 -0.931 0.252 -3.703 0.017 
3_67 - 0.3_67 == 0 -0.091 0.252 -0.362 1.000 
3_47 - 0.3_47 == 0 0.142 0.252 0.566 1.000 
3_107 - 0.3_107 == 0 -0.055 0.252 -0.218 1.000 
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Appendix C. Mussel growth (mass) multiple comparison tests by treatment group and 
sample date. P-values adjusted by Bonferroni correction.   
Pairwise comparisons Estimate Standard Errror  Z - value P ( > | Z | ) 
G
ro
w
th
 (
m
as
s)
 
Control_67 - 300_67 == 0 1.432 0.292 4.908 <0.01 
Control_67 - 30_67 == 0 1.340 0.292 4.591 <0.01 
Control_67 - 3_67 == 0 0.870 0.292 2.983 0.160 
Control_67 - 0.3_67 == 0 0.957 0.292 3.279 0.071 
Control_47 - 300_47 == 0 1.428 0.292 4.893 <0.01 
Control_47 - 30_47 == 0 1.035 0.292 3.547 0.031 
Control_47 - 3_47 == 0 1.442 0.292 4.941 <0.01 
Control_47 - 0.3_47 == 0 1.299 0.292 4.452 <0.01 
Control_107 - 300_107 == 0 1.741 0.292 5.968 <0.01 
Control_107 - 30_107 == 0 1.589 0.292 5.444 <0.01 
Control_107 - 3_107 == 0 0.891 0.292 3.054 0.133 
Control_107 - 0.3_107 == 0 1.202 0.292 4.119 <0.01 
300_67 - 30_67 == 0 -0.092 0.292 -0.317 1.000 
300_67 - 3_67 == 0 -0.562 0.292 -1.925 0.841 
300_67 - 0.3_67 == 0 -0.475 0.292 -1.629 0.953 
300_47 - 30_47 == 0 -0.393 0.292 -1.346 0.992 
300_47 - 3_47 == 0 0.014 0.292 0.047 1.000 
300_47 - 0.3_47 == 0 -0.129 0.292 -0.441 1.000 
300_107 - 30_107 == 0 -0.153 0.292 -0.524 1.000 
300_107 - 3_107 == 0 -0.850 0.292 -2.914 0.191 
300_107 - 0.3_107 == 0 -0.539 0.292 -1.849 0.878 
30_67 - 3_67 == 0 -0.469 0.292 -1.609 0.957 
30_67 - 0.3_67 == 0 -0.383 0.292 -1.313 0.993 
30_47 - 3_47 == 0 0.407 0.292 1.394 0.988 
30_47 - 0.3_47 == 0 0.264 0.292 0.905 1.000 
30_107 - 3_107 == 0 -0.698 0.292 -2.391 0.522 
30_107 - 0.3_107 == 0 -0.387 0.292 -1.325 0.993 
3_67 - 0.3_67 == 0 0.086 0.292 0.296 1.000 
3_47 - 0.3_47 == 0 -0.143 0.292 -0.489 1.000 
3_107 - 0.3_107 == 0 0.311 0.292 1.066 0.999 
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Appendix D. Mussel gonadosomatic index (GSI) multiple comparison tests by treatment 
group and sample date. P-values adjusted by Bonferroni correction.   
Pairwise comparisons Estimate Standard Errror  Z - value P ( > | Z | ) 
G
on
ad
os
om
at
ic
 I
nd
ex
 (
G
S
I)
 
Control_67 - 300_67 == 0 1.432 0.292 4.908 <0.01 
Control_67 - 30_67 == 0 1.340 0.292 4.591 <0.01 
Control_67 - 3_67 == 0 0.870 0.292 2.983 0.160 
Control_67 - 0.3_67 == 0 0.957 0.292 3.279 0.071 
Control_47 - 300_47 == 0 1.428 0.292 4.893 <0.01 
Control_47 - 30_47 == 0 1.035 0.292 3.547 0.031 
Control_47 - 3_47 == 0 1.442 0.292 4.941 <0.01 
Control_47 - 0.3_47 == 0 1.299 0.292 4.452 <0.01 
Control_107 - 300_107 == 0 1.741 0.292 5.968 <0.01 
Control_107 - 30_107 == 0 1.589 0.292 5.444 <0.01 
Control_107 - 3_107 == 0 0.891 0.292 3.054 0.133 
Control_107 - 0.3_107 == 0 1.202 0.292 4.119 <0.01 
300_67 - 30_67 == 0 -0.092 0.292 -0.317 1.000 
300_67 - 3_67 == 0 -0.562 0.292 -1.925 0.841 
300_67 - 0.3_67 == 0 -0.475 0.292 -1.629 0.953 
300_47 - 30_47 == 0 -0.393 0.292 -1.346 0.992 
300_47 - 3_47 == 0 0.014 0.292 0.047 1.000 
300_47 - 0.3_47 == 0 -0.129 0.292 -0.441 1.000 
300_107 - 30_107 == 0 -0.153 0.292 -0.524 1.000 
300_107 - 3_107 == 0 -0.850 0.292 -2.914 0.191 
300_107 - 0.3_107 == 0 -0.539 0.292 -1.849 0.878 
30_67 - 3_67 == 0 -0.469 0.292 -1.609 0.957 
30_67 - 0.3_67 == 0 -0.383 0.292 -1.313 0.993 
30_47 - 3_47 == 0 0.407 0.292 1.394 0.988 
30_47 - 0.3_47 == 0 0.264 0.292 0.905 1.000 
30_107 - 3_107 == 0 -0.698 0.292 -2.391 0.522 
30_107 - 0.3_107 == 0 -0.387 0.292 -1.325 0.993 
3_67 - 0.3_67 == 0 0.086 0.292 0.296 1.000 
3_47 - 0.3_47 == 0 -0.143 0.292 -0.489 1.000 
3_107 - 0.3_107 == 0 0.311 0.292 1.066 0.999 
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Appendix E. Mussel condition index (CI) multiple comparison tests by treatment group 
and sample date. P-values adjusted by Bonferroni correction.   
 
Pairwise comparisons Estimate Standard Errror  Z - value P ( > | Z | ) 
C
on
di
ti
on
 I
nd
ex
 
Control_67 - 300_67 == 0 0.723 0.256 2.821 0.236 
Control_67 - 30_67 == 0 0.473 0.256 1.844 0.880 
Control_67 - 3_67 == 0 0.544 0.256 2.125 0.718 
Control_67 - 0.3_67 == 0 0.633 0.256 2.471 0.460 
Control_47 - 300_47 == 0 0.396 0.256 1.546 0.969 
Control_47 - 30_47 == 0 0.497 0.256 1.941 0.832 
Control_47 - 3_47 == 0 0.556 0.256 2.169 0.686 
Control_47 - 0.3_47 == 0 0.438 0.256 1.708 0.931 
Control_107 - 300_107 == 0 0.782 0.256 3.054 0.133 
Control_107 - 30_107 == 0 0.824 0.256 3.217 0.084 
Control_107 - 3_107 == 0 0.491 0.256 1.917 0.844 
Control_107 - 0.3_107 == 0 1.118 0.256 4.364 <0.01 
300_67 - 30_67 == 0 -0.250 0.256 -0.977 1.000 
300_67 - 3_67 == 0 -0.178 0.256 -0.696 1.000 
300_67 - 0.3_67 == 0 -0.090 0.256 -0.349 1.000 
300_47 - 30_47 == 0 0.101 0.256 0.395 1.000 
300_47 - 3_47 == 0 0.160 0.256 0.623 1.000 
300_47 - 0.3_47 == 0 0.042 0.256 0.162 1.000 
300_107 - 30_107 == 0 0.042 0.256 0.163 1.000 
300_107 - 3_107 == 0 -0.291 0.256 -1.137 0.999 
300_107 - 0.3_107 == 0 0.336 0.256 1.31 0.994 
30_67 - 3_67 == 0 0.072 0.256 0.28 1.000 
30_67 - 0.3_67 == 0 0.161 0.256 0.627 1.000 
30_47 - 3_47 == 0 0.059 0.256 0.229 1.000 
30_47 - 0.3_47 == 0 -0.060 0.256 -0.232 1.000 
30_107 - 3_107 == 0 -0.333 0.256 -1.3 0.994 
30_107 - 0.3_107 == 0 0.294 0.256 1.147 0.998 
3_67 - 0.3_67 == 0 0.089 0.256 0.347 1.000 
3_47 - 0.3_47 == 0 -0.118 0.256 -0.461 1.000 
3_107 - 0.3_107 == 0 0.627 0.256 2.447 0.479 
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Appendix F. Plots of residuals from clearance rates model (e.g. mussel experiments). 
Model fit a normal distribution after data underwent Box-Cox transformation. 
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Appendix G. Plots of residuals from mussel growth (length) model. Model fit a normal 
distribution after data was log-transformed. 
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Appendix H. Plots of residuals from mussel growth (mass) model. Model fit a normal 
distribution after data was log-transformed. 
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Appendix I. Plots of residuals from mussel gonadosomatic index model. Model fit a 
normal distribution after data was log-transformed. 
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Appendix J. Plots of residuals from mussel condition index model. Model fit a normal 
distribution after data was log-transformed. 
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Appendix K. Plots of residuals from crab active behaviors model. Model fit a binomial 
error distribution.  
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Appendix L. Plots of residuals from crab predator avoidance behaviors model. Model fit 
a binomial error distribution. 
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Appendix M.  A record of modification to the initial study proposal   
 This section provides a detailed record of all modifications made to the study 
design and methodology in the initial study proposal. A copy of the proposal is provided 
here for reference. Wherever a modification was made to the study design an endnote 
was added to provide explanation of the reason for the modification and any other 
relevant details.  
 
Project Title: Multiple stressor effects of pharmaceuticals on Oregon’s rocky intertidal 
communities: A case study of fluoxetine and carbamazepine 
 
Methods   
-Laboratory Experiments- 
1.Animal Collection, Housing and Husbandry 
1.1. Collection and Aquaria conditions 
I will collect 525, 2-3 cm, Mytilus californianus mussels from the mussel bed at 
Boiler Bay, Oregon1. Collected animals will be housed in 60-liter tanks in Portland State 
University. Each tank is attached to its own ﬁltration, a biobag ﬁlter will be used to ﬁlter 
mussel waste products from the aquaria. Aquarium conditions (e.g., salinity, temperature, 
light cycle) will reflect in situ conditions at time of mussel collection. Specifically, water 
salinity will be kept between 32 and 35 ppt, using artificial seawater from Instant Ocean 
salts. The light cycle will reflect summer daylight hours (14 hours light, 10 hours dark). 
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Water temperature will be kept between 12-15 °C (55-60°F) and will be regulated using 
non-toxic glycol-based chillers. 
Upon arrival at PSU, mussels will be weighed and measured and will then be 
divided into three weight classes. From each weight class, 7 mussels will be selected at 
random and placed into housing tanks for a total of 21 mussels per tank (21mussels/tank 
X 25 treatment tanks with mussels = 525 mussels total). Mussels will be labeled using 
different colored acrylic nail polish2. To reduce stress on the animals from handling, 
mussels will be placed onto watch glasses for a total of 7 mussels per watch glass. 
Mussels will be allowed an acclimation period of 7 days to reattach byssal threads to the 
watch glass3. After 7 days, the mass of each watch glass group will then be measured 
collectively, and then repeatedly throughout the study, however individual lengths and 
widths will be measured separately using a small ruler4.  
1.2. Feeding 
Mussels will be fed using Shellfish Diet 1800 from Reed Mariculture at amounts 
per mussel following Rodriguez del Rey et al. (2011). Each mussel will be fed 0.41 mL 
of shellfish diet at each feeding event, every 5 days. 8.61 mL of shellfish diet (0.41mL X 
21 mussels/tank)5 will be added to each housing tank using a calibrated syringe. To 
measure feeding rates, water samples will be taken 1 minute after adding the shellfish 
diet and approximately one hour after, and samples will be collected again. To measure 
  
79 
 
differences in chlorophyll a concentration, samples will be analyzed using 
spectrophotometry6.  
 
1.3. Water changes 
Every 30 days a 75% partial water change will be performed. The biofilter bags 
will filter the nitrogenous wastes from mussels, however it is important to replace the 
majority of the water each month. This will be done along the same timeline as the 10-
day dosing for each treatment, including adding 0.01% ethanol (EtOH)7 to the controls 
tanks with and without mussels. The 0.01% EtOH will be added to account for the 
fluoxetine treatment reagents, which use the ethanol. Tanks will not be allowed to 
completely dry because of the risk of damaging bacteria colonies on the biobag filters.  
2. Exposure to fluoxetine  
2.1. 90-day8 exposure study design 
Mussels will be exposed to one of four fluoxetine levels (0.5, 2.0, 5.0, 10.0µg/l)9 
following environmentally relevant concentrations determined by Choong et al. (2006).  
Two control treatments, with and without mussels, with no fluoxetine (0µg/l) but with 
0.01% EtOH will be used to determine if there is an effect of fluoxetine treatment. Using 
a block design, there will be 30 tanks with a random assortment of four treatment and two 
control types with a total n=5 per treatment (Figure 1). Fluoxetine will be added to 
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treatment tanks on day 1, and then added every 10 days to mimic pulse events of 
contaminant delivery. 
 
2.1.1 Measurements 
a. Growth rates 
Each mussel will be identified using rack, tank, watch glass number, and nail 
polish color (blue, red, green, purple, yellow, orange, pink) (e.g., 321B = rack 3, tank 2, 
watch glass 1, blue). Every 10 days mussels10 will be measured for group wet-weight (per 
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watchglass) and individual length and width. Shell thickness of individuals will be 
measured by notching their shells at the beginning of the study. Accretion rate11 will be 
based on the amount of measured growth over the time interval between measurements 
(10 days). 
 
b. Feeding rates 
 Feeding behavior/rate will be monitored every 10 days12 while the animals are 
fed. As outlined above, feeding rates will be measured per tank as a function of the 
difference in chlorophyll a concentrations at the time of feeding and 60 minutes after. To 
estimate individual feeding rates, the tank measurement will then be divided by the total 
number of mussels (n=21).  
c. Reproductive function/other physiological responses 
 Every 30 days13, 6 random individuals from each group will be sacrificed from 
each tank to measure gametogenic activity. Here, gametogenic activity is characterized 
by measuring the gonadosomatic index (weight of gonad/soft tissue weight; GSI), 
following Gagne et al. 2009).  
d. Water samples14 
To keep a running background of concentrations of fluoxetine for each treatment 
tank, water samples will be taken on day one, then every 10 days prior to fluoxetine 
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addition, and frozen until analyzed using protocols adapted from Rodriguez del Rey et al. 
(2011). Water samples will be collected from the respective tanks in the following order: 
control without mussels > control with mussels > 0.5µg/L> 2.5µg/L> 5.0µg/L>10µg/L. 
50mL of water from each tank will be extracted using a calibrated syringe and then 
filtered through a centrifuge tube with Whatman glass fiber filters into a 50mL centrifuge 
tube. These samples will then be frozen until they are ready for preparation and analysis. 
Samples will be analyzed using a Fluoxetine enzyme-linked immunosorbent assay 
(ELISA) test kit to detect for the presence of fluoxetine.  
-Field Experiments-15 
1. Study Sites 
A 16-week long field experiments will be conducted at the same location as 
mussels collected for laboratory experiments, Boiler Bay, OR (44°83’N, 124°06’W).  
2. Exposure to Fluoxetine and Carbamazepine  
The pharmaceutical drugs carbamazepine and fluoxetine will be used to test H2 
and H3, whether there is a cumulative effect of multiple stressors from these 
contaminants on mussel growth, byssal thread integrity, and resistance to predation. Six 
treatments (fluoxetine (2 levels), carbamazepine (2 levels), fluoxetine + carbamazepine 
(lowest and highest level combinations)) and a control (agar) will be administered using 
diffusing devices at 4 sites at Yachats (Figure 2).  To test for caging effects, cage controls 
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(no cages) will be used for each treatment. At these cage control sites, Pisaster will be 
removed manually every two weeks. 
Because exposure experiments will be used in conjunction with predator 
manipulation, predator exclusion cages will be outfitted with contaminant diffusing 
systems (CDS). This will consist of wire cages mounted to the rock wall with bolts and a 
layer of neoprene to ensure no entry from seastars beneath the wire. The contaminant 
diffusion system will be secured to this cage by using a previously assembled PVC 
square with 4, one-inch diameter holes drilled into each arm (see Figure 2 for schematic). 
Film canisters filled with a set agar gel containing the contaminant (e.g., fluoxetine, 
carbamazepine, or both) will be secured into these holes for contaminant diffusion. These 
will then be replaced every 4 weeks with a new canister to ensure chronic, near-constant 
exposure to mussels within the cages and neighboring mussels. Every 2 weeks, mussel 
and seawater samples at 0m (within cage), 0.5m, 1m, 2m, and 5m outside of the CDS 
cages will be collected and analyzed using ELISA kits for presence of contaminants. 
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a. Mussel Growth 
At each exposure level (e.g., distance interval from CDS cage), 10 mussels will be 
identified using colored nail polish. Every 2 weeks, total length will be measured.  
b. Byssal thread integrity  
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The attachment strength of Mytilus californianus will be measured following 
methods of Harger (1970). Mussels will be hooked onto a spring dynamometer 
(constructed to record maximum force) with a wire loop. A pulling force will be applied 
perpendicular to the mussel bed until the hooked mussel is dislodged. This will be done 
for 5 mussels at each exposure level every two weeks. 
c. Predation intensity experiment 
I will measure predation intensity following a design similar to Navaratte and 
Menge  (1996).  In this case the stressors will the individual contaminants or the 
combination of the two contaminants and the primary effect will be mussel resistance to 
predation. As mentioned earlier CDS cages will be placed within either a control or 
treatment plot. In the cages where seastars are removed (P-) cages will have a roof and 
four sides. In predator control plots  (P+), seastars will have access through cages that 
have two open sides, to account for potential caging effects. In control areas without 
contamination, CDS cages (two open sides) will be filled with canisters of agar gel. 
Every two weeks cages will be monitored and maintained to ensure predator 
removal. Small and medium sized seastars, as well as other benthic predators such as 
crabs are capable of entering cages. Upon each visit, the number of live and dead mussels 
remaining in cages and controls will be counted.  
3. Statisical analyses16 
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Analysis of variance (ANOVA) will be used to determine if there are differences 
between each treatment and the controls. ANOVA assumptions of independence, 
normality, and homogeneity of the variances of the residuals will be met by using their 
appropriate tests. Tank samples will maintain independence by being isolated from one 
another, including water and filtration. Field samples will maintain independence by 
having an appropriate amount of space from one another (e.g. >50m). Both field and tank 
samples will be tested for normality and equal variance by using the Shapiro-Wilk test 
and F-test respectively. All statistical analyses will be performed using R studio version 
2.11.1.  
1.  M. californianus mussels were collected from a single location on the jetty north of 
Rockaway Beach, Oregon (45°39’18.4”N, 123°56’31.2”W)  
2. Mussels were enumerated using super glue and water proof paper labels. Nail polish 
flaked off after 2 weeks, during the acclimation period.   
3. Mussels were acclimated for one month, not 7 days.  
4. Mussels were weighed individually on 3 sample dates: 47, 67, 107. On days 47 and 67 
mussels were weighed and measured and individuals not sacrificed were placed back in 
tanks.  
5. We modified feeding based on feedback from Reed Mariculture: Twice weekly, 
mussels were batch fed Shellfish Diet 1800® (Reed Mariculture) diluted tenfold with 
seawater. The algae in the Shellfish Diet 1800® is a combination of six marine 
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microalgae Isochrysis, Pavlova, Tetraselmis, Chaetocerous calcitrans, Thalassiosira 
weissflogii and Thalassiosira pseudonana with cell diameter sizes ranging from 5 to 16 
µm. Per mussel volume of algae fed was constant throughout the study. 
6. Clearance rates were determined using the following modified methods: On feeding 
days, a 10 mL seawater sample was obtained ~1 minute after the algae mixture was 
added to each of the tanks.  Mussels were allowed to feed for 3 hours before an additional 
10mL sample was extracted. These samples served as initial and final concentrations, 
respectively.  From each sample, we counted algal cells in three 0.5 mL aliquots using a 
Beckman Coulter Counter (model Z1, 100 µm aperture) and determined the mean initial 
and final concentrations within each tank.  We collected a total of 11 samples over the 
course of the 107 day study.  
Filtering rates were estimated from the rate of change in suspended particle 
concentrations. Following Coughlan (1969), we based filtering rates on four assumptions: 
a) the reduction in the concentration of particles is due to filtration by the animal, and to 
settling, b) mussel pumping rate is constant, c) particle retention is 100% efficient and d) 
there is homogenous suspension of particles. A set of identical tanks without mussels 
(n=4) served as blanks for feeding trials.  Clearance rates for each mussel were calculated 
using the following formula (Coughlin 1969): 
CR= (M/n) [ln (C0/Ct)/t] – [ln (C0blank/Ctblank)/t] 
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where CR = clearance rate (cells-1mL-1min-1); M = volume of seawater in each tank (mL); 
n = number of mussels in tank; t = feeding time (min); C0 = initial concentration of 
particles in tank; Ct  = final concentration of particles in tank. C0blank = initial 
concentration of particles in tank without mussels; Ctblank = final concentration of 
particles in tank without mussels 
7. Because fluoxetine is water soluble, we did not use 0.1% EtOH to increase the 
solubility of the solid. Fluoxetine hydrochloride was dissolved only in nanopure water.  
8.Study period was 107 days for mussel experiment 
9.Fluxoetine treatments were 0.3, 3, 30, and 300 ng/L of fluoxetine and a control with no 
fluoxetine (Figure 2.1). A set of 5 tanks with no mussels were used to determine a 
baseline for algae removed by the tank filtration systems during algal clearance trials. We 
note that one of the no-mussel tanks malfunctioned after 20 days into the experiment and 
was excluded from further analyses, reducing no-mussel tank replicates to 4. 
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10. Made measurements on day 47, 67, and 107 
11. Did not measure shell accretion rates 
12.Algal clearance rates were measured twice weekly, except in the event where the 
Coulter counter machine was not working.  
13. Made measurments on day 47,67, and 107. 
14. Bioconcentraion of fluoxetine was transerferred to Dylan Dayrit as an undergraduate 
thesis project under the direction of Dr. Elise Granek. Samples were preserved in the -80 
freezer in the Granek/de Rivera Lab.  
15. Did not do a field component or use the pharmaceutical carbamazepine. Designed a 
predator avoidance experiment using Fluoxetine instead.  
16. Statistical analyses were modified to the following procedures:  
Fluoxetine exposure study: M. californianus:  
For each sampling period, we averaged within-tank means for mussel growth, 
GSI, CI, and algal clearance parameters. Normality and homogeneity of variances were 
assessed through graphical inspection of the model residuals and respective Shapiro-
Wilk’s and Levene’s tests, which indicated a need for data transformation. Algal 
clearance data underwent a Box-Cox transformation (Box and Cox 1964) and mussel 
growth and body condition data were log-transformed. Separate two-way ANOVAs were 
run with treatment and sample date as fixed factors and tanks as an error term to account 
  
90 
 
for non-independence between subsamples. Main effects were considered significant at 
α=0.5. Post-hoc Tukey HSD tests were used for pairwise comparisons among treatment 
and sample date means. All statistical analyses were performed using R statistical 
platform (RStudio Version 3.2.2 (2015)).  
Fluoxetine exposure study: H. oregonensis: 
Ethograms from the trials were analyzed for crab behavior and predation risk. We 
assessed differences in the proportion of active behaviors among H. oregonensis across 
fluoxetine treatments, time period type (day and night), and trial type (predator/no 
predator). To determine this proportion, we a priori divided active behaviors (i.e., 
walking, digging, foraging, and interactions between conspecifics) and non-active 
behaviors (i.e., remaining still, buried, or just moving mandibles). We then tested whether 
the probability that crabs would exhibit active behaviors varied among the three 
fluoxetine treatment groups, time periods, and trial type, or a combination of these 
variables, with a mixed-effect generalized linear model with a binomial error distribution 
using the glmer function from lme4 package (Bates et al., 2015) in R Studio (R Core 
Team, 2015). Our mixed-effect model included the crabs, trials, and tanks as random 
effects to account for non-independence between samples, due to repeatedly observing 
the same crabs over several trials and because of influences of behavior by individuals 
within the same tank. 
We used a similar modeling approach to assess whether the proportion of predator 
avoidance behaviors varied by fluoxetine treatment and over time. Using data from 
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predator trials only, we a priori determined predator avoidance behaviors as remaining 
buried, still, or retreat under rock/elsewhere in tank and non-avoidance behaviors as 
remaining active, foraging, or interacting without response to the predator. We used a 
separate mixed-effects generalized linear model with a binomial error distribution to test 
the probability that crabs would exhibit predator avoidance behaviors differently among 
the three fluoxetine treatment groups and day/night time periods.  
We were also interested in whether aggression among conspecifics varied across 
fluoxetine treatments.  We developed a third generalized mixed effects model with a 
binomial error distribution that tested whether the proportion of aggressive acts between 
H. oregonensis varied across the fluoxetine treatments, time of day, and trial type. 
 
 
 
